|
1
|
Martel-Pelletier J, Barr AJ, Cicuttini FM,
Conaghan PG, Cooper C, Goldring MB, Goldring SR, Jones G, Teichtahl
AJ and Pelletier JP: Osteoarthritis. Nat Rev Dis Primers.
2:160722016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Goldring SR and Goldring MB: Changes in
the osteochondral unit during osteoarthritis: Structure, function
and cartilage-bone crosstalk. Nat Rev Rheumatol. 12:632–644. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hugle T and Geurts J: What drives
osteoarthritis?-synovial versus subchondral bone pathology.
Rheumatology (Oxford). 56:1461–1471. 2017.
|
|
4
|
Huebner JL, Hanes MA, Beekman B, TeKoppele
JM and Kraus VB: A comparative analysis of bone and cartilage
metabolism in two strains of guinea-pig with varying degrees of
naturally occurring osteoarthritis. Osteoarthritis Cartilage.
10:758–767. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Eriksen EF: Cellular mechanisms of bone
remodeling. Rev Endocr Metab Disord. 11:219–227. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bailey AJ, Mansell JP, Sims TJ and Banse
X: Biochemical and mechanical properties of subchondral bone in
osteoarthritis. Biorheology. 41:349–358. 2004.PubMed/NCBI
|
|
7
|
Radin EL and Rose RM: Role of subchondral
bone in the initiation and progression of cartilage damage. Clin
Orthop Relat Res. 34–40. 1986.PubMed/NCBI
|
|
8
|
Bellido M, Lugo L, Roman-Blas JA,
Castañeda S, Caeiro JR, Dapia S, Calvo E, Largo R and
Herrero-Beaumont G: Subchondral bone microstructural damage by
increased remodelling aggravates experimental osteoarthritis
preceded by osteoporosis. Arthritis Res Ther. 12:R1522010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhu S, Chen K, Lan Y, Zhang N, Jiang R and
Hu J: Alendronate protects against articular cartilage erosion by
inhibiting subchondral bone loss in ovariectomized rats. Bone.
53:340–349. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Khorasani MS, Diko S, Hsia AW, Anderson
MJ, Genetos DC, Haudenschild DR and Christiansen BA: Effect of
alendronate on post-traumatic osteoarthritis induced by anterior
cruciate ligament rupture in mice. Arthritis Res Ther. 17:302015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Miyauchi Y, Sato Y, Kobayashi T, Yoshida
S, Mori T, Kanagawa H, Katsuyama E, Fujie A, Hao W, Miyamoto K, et
al: HIF1alpha is required for osteoclast activation by estrogen
deficiency in postmenopausal osteoporosis. Proc Natl Acad Sci USA.
110:16568–16573. 2013. View Article : Google Scholar
|
|
12
|
Cui Z, Xu C, Li X, Song J and Yu B:
Treatment with recombinant lubricin attenuates osteoarthritis by
positive feedback loop between articular cartilage and subchondral
bone in ovariectomized rats. Bone. 74:37–47. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li X, Zhang Y, Kang H, Liu W, Liu P, Zhang
J, Harris SE and Wu D: Sclerostin binds to LRP5/6 and antagonizes
canonical Wnt signaling. J Biol Chem. 280:19883–19887. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
van Bezooijen RL, ten Dijke P, Papapoulos
SE and Löwik CW: SOST/sclerostin, an osteocyte-derived negative
regulator of bone formation. Cytokine Growth Factor Rev.
16:319–327. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jia H, Ma X, Wei Y, Tong W, Tower RJ,
Chandra A, Wang L, Sun Z, Yang Z, Badar F, et al: Loading-induced
reduction in sclerostin as a mechanism of subchondral bone plate
sclerosis in mouse knee joints during late-stage osteoarthritis.
Arthritis Rheumatol. 70:230–241. 2018. View Article : Google Scholar
|
|
16
|
Robling AG, Niziolek PJ, Baldridge LA,
Condon KW, Allen MR, Alam I, Mantila SM, Gluhak-Heinrich J, Bellido
TM, Harris SE and Turner CH: Mechanical stimulation of bone in vivo
reduces osteocyte expression of Sost/sclerostin. J Biol Chem.
283:5866–5875. 2008. View Article : Google Scholar
|
|
17
|
Lin C, Jiang X, Dai Z, Guo X, Weng T, Wang
J, Li Y, Feng G, Gao X and He L: Sclerostin mediates bone response
to mechanical unloading through antagonizing Wnt/beta-catenin
signaling. J Bone Miner Res. 24:1651–1661. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tu X, Rhee Y, Condon KW, Bivi N, Allen MR,
Dwyer D, Stolina M, Turner CH, Robling AG, Plotkin LI and Bellido
T: Sost downregulation and local Wnt signaling are required for the
osteogenic response to mechanical loading. Bone. 50:209–217. 2012.
View Article : Google Scholar
|
|
19
|
Sims NA and Johnson RW: Leukemia
inhibitory factor: A paracrine mediator of bone metabolism. Growth
Factors. 30:76–87. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Koide M, Kobayashi Y, Yamashita T, Uehara
S, Nakamura M, Hiraoka BY, Ozaki Y, Iimura T, Yasuda H, Takahashi N
and Udagawa N: Bone formation is coupled to resorption via
suppression of sclerostin expression by osteoclasts. J Bone Miner
Res. 32:2074–2086. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Burr DB and Gallant MA: Bone remodelling
in osteoarthritis. Nat Rev Rheumatol. 8:665–673. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cui Z, Crane J, Xie H, Jin X, Zhen G, Li
C, Xie L, Wang L, Bian Q, Qiu T, et al: Halofuginone attenuates
osteoarthritis by inhibition of TGF-beta activity and H-type vessel
formation in subchondral bone. Ann Rheum Dis. 75:1714–1721. 2016.
View Article : Google Scholar
|
|
23
|
Zhen G, Wen C, Jia X, Li Y, Crane JL,
Mears SC, Askin FB, Frassica FJ, Chang W, Yao J, et al: Inhibition
of TGF-beta signaling in mesenchymal stem cells of subchondral bone
attenuates osteoarthritis. Nat Med. 19:704–712. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ji B, Zhang Z, Guo W, Ma H, Xu B, Mu W,
Amat A and Cao L: Isoliquiritigenin blunts osteoarthritis by
inhibition of bone resorption and angiogenesis in subchondral bone.
Sci Rep. 8:17212018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Klayman DL: Qinghaosu (artemisinin): An
antimalarial drug from China. Science. 228:1049–1055. 1985.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tu Y: The development of new antimalarial
drugs: Qinghaosu and dihydro-qinghaosu. Chin Med J (Engl).
112:976–977. 1999.
|
|
27
|
Zhou L, Liu Q, Yang M, Wang T, Yao J,
Cheng J, Yuan J, Lin X, Zhao J, Tickner J and Xu J:
Dihydroartemisinin, an anti-malaria drug, suppresses estrogen
deficiency-induced osteoporosis, osteoclast formation, and
RANKL-induced signaling pathways. J Bone Miner Res. 31:964–974.
2016. View Article : Google Scholar
|
|
28
|
Feng MX, Hong JX, Wang Q, Fan YY, Yuan CT,
Lei XH, Zhu M, Qin A, Chen HX and Hong D: Dihydroartemisinin
prevents breast cancer-induced osteolysis via inhibiting both
breast caner cells and osteoclasts. Sci Rep. 6:190742016.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Glasson SS, Blanchet TJ and Morris EA: The
surgical destabilization of the medial meniscus (DMM) model of
osteoarthritis in the 129/SvEv mouse. Osteoarthritis Cartilage.
15:1061–1069. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhao YG, Wang Y, Guo Z, Gu AD, Dan HC,
Baldwin AS, Hao W and Wan YY: Dihydroartemisinin ameliorates
inflammatory disease by its reciprocal effects on Th and regulatory
T cell function via modulating the mammalian target of rapamycin
pathway. J Immunol. 189:4417–4425. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhou S, Wang G, Qiao L, Ge Q, Chen D, Xu
Z, Shi D, Dai J, Qin J, Teng H and Jiang Q: Age-dependent
variations of cancellous bone in response to ovariectomy in
C57BL/6J mice. Exp Ther Med. 15:3623–3632. 2018.PubMed/NCBI
|
|
32
|
Mapp PI and Walsh DA: Mechanisms and
targets of angiogenesis and nerve growth in osteoarthritis. Nat Rev
Rheumatol. 8:390–398. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xie H, Cui Z, Wang L, Xia Z, Hu Y, Xian L,
Li C, Xie L, Crane J, Wan M, et al: PDGF-BB secreted by
preosteoclasts induces angiogenesis during coupling with
osteogenesis. Nat Med. 20:1270–1278. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Matsuo K and Irie N: Osteoclast-osteoblast
communication. Arch Biochem Biophys. 473:201–209. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sims NA and Martin TJ: Coupling the
activities of bone formation and resorption: A multitude of signals
within the basic multicellular unit. Bonekey Rep. 3:4812014.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kamekura S, Hoshi K, Shimoaka T, Chung U,
Chikuda H, Yamada T, Uchida M, Ogata N, Seichi A, Nakamura K and
Kawaguchi H: Osteoarthritis development in novel experimental mouse
models induced by knee joint instability. Osteoarthritis Cartilage.
13:632–641. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Honma M, Ikebuchi Y, Kariya Y and Suzuki
H: Regulatory mechanisms of RANKL presentation to osteoclast
precursors. Curr Osteoporos Rep. 12:115–120. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Miyatake K, Muneta T, Ojima M, Yamada J,
Matsukura Y, Abula K, Sekiya I and Tsuji K: Coordinate and
synergistic effects of extensive treadmill exercise and ovariectomy
on articular cartilage degeneration. BMC Musculoskelet Disord.
17:2382016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sniekers YH, Weinans H, Bierma-Zeinstra
SM, van Leeuwen JP and van Osch GJ: Animal models for
osteoarthritis: The effect of ovariectomy and estrogen treatment-a
systematic approach. Osteoarthritis Cartilage. 16:533–541. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Bijlsma JW, Berenbaum F and Lafeber FP:
Osteoarthritis: An update with relevance for clinical practice.
Lancet. 377:2115–2126. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Goldring MB and Goldring SR: Articular
cartilage and subchondral bone in the pathogenesis of
osteoarthritis. Ann N Y Acad Sci. 1192:230–237. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Bultink IE and Lems WF: Osteoarthritis and
osteoporosis: What is the overlap? Curr Rheumatol Rep. 15:3282013.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Baron R and Kneissel M: WNT signaling in
bone homeostasis and disease: From human mutations to treatments.
Nat Med. 19:179–192. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Song L, Liu M, Ono N, Bringhurst FR,
Kronenberg HM and Guo J: Loss of wnt/β-catenin signaling causes
cell fate shift of preosteoblasts from osteoblasts to adipocytes. J
Bone Miner Res. 27:2344–2358. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
van Bezooijen RL, Roelen BA, Visser A, van
der Wee-Pals L, de Wilt E, Karperien M, Hamersma H, Papapoulos SE,
ten Dijke P and Löwik CW: Sclerostin is an osteocyte-expressed
negative regulator of bone formation, but not a classical BMP
antagonist. J Exp Med. 199:805–814. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Li X, Ominsky MS, Warmington KS, Morony S,
Gong J, Cao J, Gao Y, Shalhoub V, Tipton B, Haldankar R, et al:
Sclerostin anti-body treatment increases bone formation, bone mass,
and bone strength in a rat model of postmenopausal osteoporosis. J
Bone Miner Res. 24:578–588. 2009. View Article : Google Scholar
|
|
47
|
Wu L, Guo H, Sun K, Zhao X, Ma T and Jin
Q: Sclerostin expression in the subchondral bone of patients with
knee osteoarthritis. Int J Mol Med. 38:1395–1402. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Walker EC, McGregor NE, Poulton IJ, Solano
M, Pompolo S, Fernandes TJ, Constable MJ, Nicholson GC, Zhang JG,
Nicola NA, et al: Oncostatin M promotes bone formation
independently of resorption when signaling through leukemia
inhibitory factor receptor in mice. J Clin Invest. 120:582–592.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Poulton IJ, McGregor NE, Pompolo S, Walker
EC and Sims NA: Contrasting roles of leukemia inhibitory factor in
murine bone development and remodeling involve region-specific
changes in vascularization. J Bone Miner Res. 27:586–595. 2012.
View Article : Google Scholar
|
|
50
|
Johnson RW, Brennan HJ, Vrahnas C, Poulton
IJ, McGregor NE, Standal T, Walker EC, Koh TT, Nguyen H, Walsh NC,
et al: The primary function of gp130 signaling in osteoblasts is to
maintain bone formation and strength, rather than promote
osteoclast formation. J Bone Miner Res. 29:1492–1505. 2014.
View Article : Google Scholar
|
|
51
|
Li X, Ominsky MS, Niu QT, Sun N, Daugherty
B, D'Agostin D, Kurahara C, Gao Y, Cao J, Gong J, et al: Targeted
deletion of the sclerostin gene in mice results in increased bone
formation and bone strength. J Bone Miner Res. 23:860–869. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
de Vries TJ and Huesa C: The osteocyte as
a novel key player in understanding periodontitis through its
expression of RANKL and sclerostin: A review. Curr Osteoporos Rep.
17:116–121. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Dong F, Zhou X, Li C, Yan S, Deng X, Cao
Z, Li L, Tang B, Allen TD and Liu J: Dihydroartemisinin targets
VEGFR2 via the NF-kB pathway in endothelial cells to inhibit
angiogenesis. Cancer Biol Ther. 15:1479–1488. 2014. View Article : Google Scholar
|
|
54
|
Ho WE, Peh HY, Chan TK and Wong WS:
Artemisinins: Pharmacological actions beyond anti-malarial.
Pharmacol Ther. 142:126–139. 2014. View Article : Google Scholar
|
|
55
|
Bei MJ, Tian FM, Xiao YP, Cao XH, Liu N,
Zheng ZY, Dai MW, Wang WY, Song HP and Zhang L: Raloxifene retards
cartilage degradation and improves subchondral bone
micro-architecture in ovariectomized rats with patella
baja-induced-patellofemoral joint osteoarthritis. Osteoarthritis
Cartilage. 28:344–355. 2020. View Article : Google Scholar
|
